QSAR analysis of a series of imidazole derivatives acting on the H 3 receptor

Revue Roumaine de Chimie

Volumn 51, Issue 4, 2006, Pages 287-292

  Mracec, Maria ^a   Juchel, Laura ^a   Mracec, Mircea ^a  

^a ACADEMY OF ROMANIAN SCIENTISTS   (Romania)

Author keywords

Hislamine H3 receptor; Imidazolic derivatives; MLR; MTD; QSAR

Indexed keywords

EID: 33748710834     PISSN: 00353930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. C. Perez-Garcia, L. Morales, M.V. Cano, I. Sancho and L.F. Alguacil, Psychopharmacology (Berl)., 1999,142, 215-20.
2. K. Takahashi, H. Suwa, T. Ishikawa and H Kotani., J. Clin. Invest., 2002, 110, 1791-1799.
3. M.B. Passani and P. Blandina, Methods Find Exp. Clin. Pharmacol., 1998, 20, 725-33.
4. H. Stark, E. Schlicker and W. Schunack, Drugs Future, 1996, 21, 507-20.
5. J.C. Schwanz, J.M. Arrang, M. Garbarg, H. Pollard and M. Ruat, Physiol. Rev., 1991, 71, 1-51.
6. R. Leurs, M. Kathmann, R.C. Vollinga, W.M.P.B. Menge, E. Schlicker and H. Timmerman, J. Pharmacol. Exp. Ther., 1996, 270, 1009-1015.
7. J.C. Schwartz, S. Morisset, A. Rouleau, X. Ligneau, F. Gbahou, J. Tardivel-Lacombe, H. Stark, W. Schunack, C.R. Ganellin and J.M. Arrang, J. Neural Transm. Suppl., 2003,64,1-16.
8. H. Stark, M. Kathmann, E. Schlicker, W. Schunack, B. Schlegel and W. Sippl, Mini Rev. Med. Chem., 2004, 4, 965-77.
9. W. Schunack and H. Stark, Eur. J. Drug Metab. Pharmacokinet., 1994, 79, 173-8.
10. A. Sasse, K. Kiec-Kononowicz, H. Stark, M. Motyl, S. Reidemeister, C.R. Ganellin, X. Ligneau, J.C. Schwanz, W. Schunack and/ Med. Chem., 1999, 42, 593-600.
11. Z. Simon, MTD and hyperstructure approaches. In 3D-QSAR in Drug Design Theory, Methods, Applications, H. Kubiny, Ed. ESCOM Leyden, 1993, p. 307-319.
12. M.J.S.Dewar, E.G. Zoebish, E.F. Healy and J.J. Stewart, J. Am. Chem. Soc., 1985, 107, 3902-3909.